Historique
Article de Périodique
Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses (2017)
Auteur(s) :
BUTLER, A. J. ;
REHM, J. ;
FISCHER, B.
Année
2017
Page(s) :
401-416
Sous-type de document :
Méta-analyse ; Revue de la littérature
Langue(s) :
Anglais
Domaine :
Drogues illicites
Discipline :
EPI (Epidémiologie / Epidemiology)
Thésaurus mots-clés
CRACK
;
MORBIDITE
;
MORTALITE
;
EFFET SECONDAIRE
;
PSYCHOPATHOLOGIE
;
PATHOLOGIE ORGANIQUE
;
COCAINE
Résumé :
Background: Crack-cocaine use is prevalent largely in socio-economically marginalized populations in the Americas. Its use has been associated with diverse health outcomes, yet no recent or systematic reviews of these exist.
Methods: A systematic review of health outcomes associated with crack-cocaine use was performed, using MEDLINE, Scopus, Web of Science, CINAHL, PsycINFO, and LILACS up to October 2016. Search terms included crack-cocaine and health outcome-related keywords, targeting peer-reviewed studies on quantified health outcomes associated with crack-cocaine use. Random effects meta-analyses produced pooled odds ratios. Levels of evidence for major results were assessed using the GRADE approach. A review protocol was registered with PROSPERO (CRD42016035486).
Results: Of 4700 articles returned, 302 met eligibility criteria, reporting on health outcomes for 14 of 22 ICD-10 chapters. Conclusive evidence and meta-analyses showed positive associations between crack-cocaine use and blood/sexually transmitted diseases (HIV and hepatitis C virus, others); moderate evidence and meta-analyses supported associations with neonatal health, and violence. There were mixed associations for mental and other health outcomes, yet insufficient evidence to perform meta-analyses for many categories (e.g., mortality). Most underlying research was of limited or poor quality, with crack-cocaine commonly assessed as a secondary covariate.
Conclusions: Crack-cocaine use was associated with a range of health outcomes, although it was unclear if there was direct causal impact, interactions between risk factors, or external drivers of both crack-cocaine use and outcomes. Rigorous epidemiological studies are needed to systematically assess health outcomes of crack-cocaine use and underlying pathways, also to inform evidence-based interventions.
Highlights:
Crack-cocaine use is common but health outcomes are not systematically reviewed.
Strong associations exist for various infectious diseases, e.g., HIV, hepatitis C.
Moderate evidence associations exist for neonatal health and violence.
Primary research is needed to understand the distinct risks and harm pathways.
Methods: A systematic review of health outcomes associated with crack-cocaine use was performed, using MEDLINE, Scopus, Web of Science, CINAHL, PsycINFO, and LILACS up to October 2016. Search terms included crack-cocaine and health outcome-related keywords, targeting peer-reviewed studies on quantified health outcomes associated with crack-cocaine use. Random effects meta-analyses produced pooled odds ratios. Levels of evidence for major results were assessed using the GRADE approach. A review protocol was registered with PROSPERO (CRD42016035486).
Results: Of 4700 articles returned, 302 met eligibility criteria, reporting on health outcomes for 14 of 22 ICD-10 chapters. Conclusive evidence and meta-analyses showed positive associations between crack-cocaine use and blood/sexually transmitted diseases (HIV and hepatitis C virus, others); moderate evidence and meta-analyses supported associations with neonatal health, and violence. There were mixed associations for mental and other health outcomes, yet insufficient evidence to perform meta-analyses for many categories (e.g., mortality). Most underlying research was of limited or poor quality, with crack-cocaine commonly assessed as a secondary covariate.
Conclusions: Crack-cocaine use was associated with a range of health outcomes, although it was unclear if there was direct causal impact, interactions between risk factors, or external drivers of both crack-cocaine use and outcomes. Rigorous epidemiological studies are needed to systematically assess health outcomes of crack-cocaine use and underlying pathways, also to inform evidence-based interventions.
Highlights:
Crack-cocaine use is common but health outcomes are not systematically reviewed.
Strong associations exist for various infectious diseases, e.g., HIV, hepatitis C.
Moderate evidence associations exist for neonatal health and violence.
Primary research is needed to understand the distinct risks and harm pathways.
Affiliation :
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada